| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 07/05/2024 | 01:46 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:CSBR | Champions Oncology Inc |
| 13/02/2024 | 03:12 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:CSBR | Champions Oncology Inc |
| 16/01/2024 | 17:45 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:CSBR | Champions Oncology Inc |
| 13/12/2023 | 22:47 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:CSBR | Champions Oncology Inc |
| 12/12/2023 | 22:14 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:CSBR | Champions Oncology Inc |
| 12/12/2023 | 11:50 | IH Market News | Hasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic Antitrust Loss, and More | NASDAQ:CSBR | Champions Oncology Inc |
| 28/08/2023 | 21:14 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:CSBR | Champions Oncology Inc |
| 28/08/2023 | 21:12 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NASDAQ:CSBR | Champions Oncology Inc |
| 24/07/2023 | 22:17 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:CSBR | Champions Oncology Inc |
| 05/04/2023 | 17:39 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CSBR | Champions Oncology Inc |
| 21/03/2023 | 17:31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CSBR | Champions Oncology Inc |
| 12/09/2022 | 22:53 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:CSBR | Champions Oncology Inc |
| 31/08/2022 | 15:29 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:CSBR | Champions Oncology Inc |
| 29/08/2022 | 21:17 | Edgar (US Regulatory) | Proxy Statment - Contested Solicitations (definitive) (defc14a) | NASDAQ:CSBR | Champions Oncology Inc |
| 22/07/2022 | 22:29 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:CSBR | Champions Oncology Inc |
| 14/02/2022 | 16:59 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CSBR | Champions Oncology Inc |
| 23/07/2021 | 19:53 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:CSBR | Champions Oncology Inc |
| 11/09/2020 | 12:04 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:CSBR | Champions Oncology Inc |
| 10/12/2018 | 22:30 | PR Newswire (US) | Champions Oncology to Announce Second Quarter Financial Results on Monday, December 17, 2018 | NASDAQ:CSBR | Champions Oncology Inc |
| 07/11/2018 | 14:30 | PR Newswire (US) | Champions Oncology to Participate in the 9th Annual Craig-Hallum Alpha Select Conference | NASDAQ:CSBR | Champions Oncology Inc |
| 13/09/2018 | 22:05 | PR Newswire (US) | Champions Oncology Reports Record Quarterly Revenue of $6.2 Million | NASDAQ:CSBR | Champions Oncology Inc |
| 13/09/2018 | 14:30 | PR Newswire (US) | Champions Oncology to Participate at the Janney Montgomery Scott Healthcare Conference 2018 in New York | NASDAQ:CSBR | Champions Oncology Inc |
| 28/08/2018 | 14:30 | PR Newswire (US) | Champions Oncology to Announce First Quarter Financial Results on Thursday, September 13, 2018 | NASDAQ:CSBR | Champions Oncology Inc |
| 08/08/2018 | 14:30 | PR Newswire (US) | Champions Oncology Granted Full Accreditation by the AAALAC | NASDAQ:CSBR | Champions Oncology Inc |
| 26/07/2018 | 22:02 | PR Newswire (US) | Champions Oncology Reports Record Annual Revenue Exceeding $20M for Fiscal Year Ended April 30, 2018 | NASDAQ:CSBR | Champions Oncology Inc |
| 12/07/2018 | 14:30 | PR Newswire (US) | Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 26, 2018 | NASDAQ:CSBR | Champions Oncology Inc |
| 18/06/2018 | 14:30 | PR Newswire (US) | Champions Oncology Partners with Puma Biotechnology and NSABP Foundation on Metastatic Breast and Colon Cancer Co-clinical PD... | NASDAQ:CSBR | Champions Oncology Inc |
| 03/05/2018 | 14:30 | PR Newswire (US) | Champions Oncology to Present at the 3rd annual Disruptive Growth & Healthcare Conference on May 9th | NASDAQ:CSBR | Champions Oncology Inc |
| 01/05/2018 | 14:30 | PR Newswire (US) | Champions Oncology Adds Amy Wesa, Ph.D, as Director of Immuno-Oncology Research | NASDAQ:CSBR | Champions Oncology Inc |
| 04/04/2018 | 14:30 | PR Newswire (US) | Champions Oncology to Present at The MicroCap Conference on April 10th in New York City at the Essex House | NASDAQ:CSBR | Champions Oncology Inc |